B · Normal
[BeiGene: Net profit increased by 431.8% year-on-year in the first three quarters] On November 5, BeiGene (688235.SH) released its main financial data for the third quarter of 2026. In the first three quarters, it achieved total operating income of 34.993 billion yuan, a year-on-year increase of 26.8%; the net profit attributable to the owners of the parent company was 6.055 billion yuan, a year-on-year increase of 431.8%. Among them, product revenue in the third quarter was 12.56 billion yuan, a year-on-year increase of 26.2%. Product revenue in the first three quarters was 34.357 billion yuan, a year-on-year increase of 25.8%, mainly due to the sales growth of Baiyueze, Baizean and Amgen authorized products.
Comments